OKYO - Ticker AI Digest
OKYO Pharma Ltd 📰 1
Important AI Risk Notice
Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.
Not investment advice.
Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate.
Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only.
Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally.
Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
OKYO Pharma Ltd in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, crunch, and the deeper desks.
OKYO
Data 2023-02-14
Preview Mode
Core Deck
Deep Dive Modules
AI Crunch
Single-Ticker AI Crunch
OKYO signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.
This is the ticker-specific AI Crunch desk for OKYO Pharma Ltd. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.
Subscription Required
Bullish vs Bearish Scoring
AI Forecast Stack
Buy / Sell Trigger Engine
Catalyst Ledger
Subscriber Unlock
Subscribe to unlock the full OKYO AI Crunch cockpit.
Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.
- AI-scored market headlines with sentiment buckets and buzzword breakdowns.
- Forecast leaders ranked by projected gain against current market price.
- Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
- Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
- Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
- Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for OKYO on 2023-02-14.
Fundamentals Matrix
Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
23223060
Enterprise Value
34144551
Public Float
0.5151277688905501
Broker Target
26029.2
Shares Out
1658790016
Long Interest
100
Short Interest
-
Exchange
LSE
Currency Code
GBX
ISIN
GG00BD3FV870
Market
LSE - MAIN MARKET
Sector
Pharmaceuticals and Biotechnology
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-
Financials Matrix
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
-
Earnings Date
-
Net Debt
-2055980.16
Cash
2055980.16
EPS
-0.01
Net Income
-4134491.63
Revenue
-
Enterprise Value
34144551
Trailing PE
-
Forward PE
-
Price Sales TTM
-
Price Book MRQ
15.6883
EV Revenue
-
EV EBITDA
-5.7261
Financial Heaven
Mixed financial engine
Net margin is compressing by 131,508.5 pts. Net debt is coming down +89.0%.
Net Income +504.6%
FCF -30.2%
Current Ratio 0.83x
Forward Rev 0
Mixed
Quarter Revenue
0
-
vs prior comparable quarter
Net Margin
-
-131508.5 pts
profitability pulse
Free Cash Flow
-266.4K
-30.2%
cash conversion
Net Debt / EBITDA
-
-89.0%
lower is cleaner
Revenue Engine
Latest quarter printed 0 with the top line stable against the last comparable period.
Profit Stack
Net income landed at -1.8M and the margin profile is tightening. That usually tells us whether operating leverage is finally kicking in.
Balance-Sheet Pressure
Cash sits near 633.6K while net debt is -633.6K. The leverage stack is cleaning up.
Quarterly Revenue Runway
Actual revenue bars, consensus revenue where available, plus the terminal model path.
Profit And Cash Conversion
Net income and free cash flow moving together is usually what separates genuine improvement from noise.
Balance-Sheet Pressure
Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.
Annual Power Curve
Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q3 2022
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q4 2022
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
FY 2023
Consensus
0
Revenue Path
-0.80
EPS / Earnings
Growth cue -
FY 2024
Consensus
0
Revenue Path
-1.61
EPS / Earnings
Growth cue -1.0%
Quarterly Statement Tape
Last 6 Quarters
| Period | Revenue | Net Income | FCF | Net Debt |
|---|---|---|---|---|
| Q3 2022 | - | - | - | -633.6K |
| Q1 2022 | - | - | - | -2.1M |
| Q4 2021 | - | - | - | - |
| Q3 2021 | - | -1.8M | - | -3.8M |
| Q2 2021 | - | - | - | - |
| Q1 2021 | - | -2.1M | - | -4.9M |
Annual Financial Power
Last 5 Years
| Period | Revenue | Net Income | EBITDA | FCF |
|---|---|---|---|---|
| FY 2022 | 0 | -4.1M | -4.7M | -4.2M |
| FY 2021 | 0 | -3.0M | -3.0M | -1.3M |
| FY 2020 | - | -1.2M | -1.2M | -1.1M |
| FY 2019 | 0 | -3.8M | -3.8M | -1.5M |
| FY 2018 | 0 | -53.1M | 51.5M | -995.7K |
Structure DNA
Market Structure DNA
Balanced Structure profile with trend broken
31.9% of the register is locked by institutions and insiders, leaving 68.1% free float. Capital rhythm reads no cadence with forward yield near 0.0% and payout around 0.0%.
Trend broken
Institutional gravity
Moderate income rhythm
As Of 2026-04-19
Balanced Structure
Structure Score
36.1 / 100
Balanced Structure
Trend Stack
-99.3% / -99.5%
vs 50DMA / 200DMA
52W Position
-
auction position inside the yearly range
Ownership Lock
31.9%
0.0% institutions | 31.9% insiders
Pressure Pocket
68.1% free float
Vendor short-float fields were not supplied
Capital Rhythm
No cadence
Yield 0.0% | payout 0.0%
Trend Runway
Implied spot is 0.01 with the stock -99.3% vs 50DMA and -99.5% vs 200DMA. The tape is sitting -% through the 52-week range, which frames the regime as trend broken.
Ownership Register
Institutions hold about 0.0% and insiders about 31.9%, locking roughly 31.9% of the register and leaving 68.1% in free float. That reads as institutional gravity.
Pressure Pocket
The API did not return a usable short-float field for this ticker, so the pressure score leans more on float lock and crowding than a full short ledger.
Capital Rhythm
Dividend cadence reads no cadence with - event(s) in the last full year, a five-year average of -, and stability score 0.0/100. Forward yield sits near 0.0% while payout is around 0.0%.
Structure Score
One-glance gauge for the current market-structure regime.
Pillar Radar
Trend, ownership, pressure, and capital rhythm mapped on one wheel.
Position And Float Balance
Shows whether the stock is extended, tightly held, or carrying capital-return support.
Dividend Cadence Tape
Historical dividend-event counts help reveal how dependable the income rhythm has been.
Dividend Cadence Ledger
No cadence
| Year | Dividend Count | Context |
|---|---|---|
| Dividend history has not been normalized yet. | ||
Structure Facts
Live Snapshot
Implied Spot
0.01
derived from market cap / shares
52W High
0.00
upper auction edge
52W Low
0.00
lower auction edge
Beta
-0.06
volatility character
Shares Out
1.7B
fully diluted count
Shares Float
8.5M
tradable register
Shares Short
0
borrowed stock
Short Ratio
0.0x
days-to-cover style read
Ex-Dividend
-
next ex-date not supplied
Dividend Pay
-
payment date not supplied
Last Split
1:5
2011-12-19
Capital Radar
Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
1658790016
Public Hands
0.5151277688905501
Institutions
-
Institutions As Of
-
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
0
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder
Short Data - Last 30 Days
Nexus Pulse Engine
Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending
Volatility Lab
ATR(14)
Realized Vol (20d)
Volume Spike Z
AI Charts
Today's Catalysts
1 live catalyst just hit OKYO.
The headlines landing in Digested News are now framed here as today's catalyst tape. Open Digested News or jump there instantly below.
Live Tape
Data 2023-02-14
AI Charts Landing View
Open Digested News any time, or use the jump button to land straight on today's tape.
1
Today
Catalyst Pulse
OKYO Pharma Ltd has fresh news flow feeding the chart narrative.
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.
Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.
Automated Signalling
Automated AI Forecasts
Predictive MACD
Catalyst Beacons
Live Price Structure
RSI Gauge
Price Change
AI Forecast